NewsRx

Search our medical news database

Personnel

Oncology company appoints new VP, sales and marketing

Published in Health and Medicine Week, January 3rd, 2005

Australian Cancer Technology (ACU) announced the appointment of Daniel C. Walding to the newly created position of VP, sales and marketing for its U.S.-based revisys medical nutritional supplements business.

"Dan brings to AustCancer more than 20 years of sales and marketing experience and joins us at a time when the seven-product line of revisys medical nutritionals is beginning to gain solid traction in the marketplace," said Paul Hopper, AustCancer's managing director.

"With Dan on board we will further refine our marketing efforts and establish additional product distribution capabilities in the U.S. and abroad. Our feedback from the market is...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health and Medicine Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook